Table GPS-2. Last 12 months prevalence of drug use in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) [see all tables in this series...]

Part (ii) Last 12 months prevalence young adults: last survey available for each Member State (from 2000 onwards)

Country		Geographical area	Year	Reference	Age range young adults	Sample size young adults	Cannabis (%)	Cocaine (%) (1)	Amphetamines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium		National	2004	(6)	15–34	:	11.3	:	:	:	:
Bulgaria		National	2008	(3)	15–34	2164	6.0	1.5	2.1	1.6	0.1
Czech Republic		National	2008	(3)	15–34	2079	28.2	1.6	3.2	7.7	4.3
Denmark		National	2008	(5)	16–34	1744	13.3	3.4	3.1	1.1	0.2
Germany		National	2006	(7)	18–34	3306	11.9	1.6	1.6	1.2	0.3
Estonia		National	2008	(3)	15–34	545	13.6	1.3	2.5	2.3	0.7
Ireland		National	2006–07	(5)	15–34	:	10.4	3.1	0.8	2.4	0.4
Greece		National (except Aegean and Ionian Islands)	2004	(3)	15–34	2620	3.2	0.2	0.1	0.4	0.2
Spain		National	2007-08	(7)	15–34	9843	18.8	5.5	1.7	2.3	:
France		National	2005	(6)	15–34	10855	16.7	1.2	0.2	1.0	0.2
Italy		National	2008	(4)	15–34	6398	20.3	2.9	0.6	1.0	:
Cyprus		National	2006	(1)	15–34	1753	3.4	0.7	0.3	1.3	0.5
Latvia		National	2007	(2)	15–34	2497	9.7	1.0	1.9	2.7	0.5
Lithuania		National	2008	(2)	15–34	2152	9.9	0.3	1.1	1.9	0.4
Luxembourg		:	:	:	:	:	:	:	:	:	:
Hungary		National	2007	(3)	18-34	1111	5.7	0.4	1.2	1.0	0.3
Malta		National	2001	(1)	18–34	640	1.9	:	:	:	:
Netherlands		National	2005	(3)	15–34	:	9.5	1.0	0.7	2.7	0.1
Austria		National	2008	(2)	15–34	2558	6.6	1.2	0.9	1.0	0.4
Poland		National	2006	(2)	15–34	2031	5.3	0.3	1.3	0.7	0.3
Portugal		National	2007	(2)	15–34	4765	6.7	1.2	0.4	0.9	0.3
Romania		National	2007	(2)	15–34	2262	0.9	0.1	0.1	0.2	0.0
Slovenia		National	2007	(1)	15–34	691	6.9	:	:	:	:
Slovakia		National	2006	(6)	15–34	556	14.7	1.3	0.7	2.7	:
Finland		National	2006	(7)	15–34	1387	8.0	0.8	1.7	1.3	0.2
Sweden		National	2008	(5)	15–34	16271	4.9	1.2	1.5	0.2	:
Sweden		National	2008	(10)	16-34	2546	4.5	:	:	:	:
United Kingdom		England and Wales	2008-09	(12)	16-34	9683	14.4	6.2	2.3	3.9	0.5
United Kingdom		Northern Ireland	2007-08	(16)	16-34	919	10.1	3.8	1.6	3.3	0.3
United Kingdom		Scotland	2006	(19)	16–34	1115	20.4	8.0	4.1	6.9	1.2
United Kingdom		United Kingdom	2006	(21)	16–34	:	15.9	5.6	2.8	4.1	0.6
Croatia		:	:	:	:	:	:	:	:	:	:
Turkey		:	:	:	:	:	:	:	:	:	:
Norway		National	2004	(2)	15–34	1238	9.6	1.8	2.0	1.2	0.4

Notes:

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy. 

 (3) For Spain: ecstasy and other synthetic drugs. 

 This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.  

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.  

 For methods and definitions see General population surveys of drug use – methods and definitions. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

                        

Sources:

 See Table GPS-0.  

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)